Business
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report – RT
A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.

A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurologi…
-
General22 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours ago
Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
General23 hours ago
Lithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News21 hours ago
Unvaccinated horse dies from Hendra virus as Queensland records first case in three years